The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
Summary: Hepatitis delta virus (HDV) is a small defective virus that needs hepatitis B virus (HBV) to replicate and propagate. HDV infection affects 20-40 million people worldwide and pegylated interferon (PegIFN) is the only recommended therapy. There is limited data on the contribution of HDV infe...
Main Authors: | Marc Puigvehí, Carlos Moctezuma-Velázquez, Augusto Villanueva, Josep M. Llovet |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-08-01
|
Series: | JHEP Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555919300345 |
Similar Items
-
Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B
by: Carlos Moctezuma-Velázquez, et al.
Published: (2021-12-01) -
Hepatitis Delta Virus and Hepatocellular Carcinoma
by: Daniele Lombardo, et al.
Published: (2024-04-01) -
Key oncogenes and candidate drugs for hepatitis-B-driven hepatocellular carcinoma progression
by: Liqin Ruan, et al.
Published: (2025-02-01) -
Liver transplantation or resection for early hepatocellular carcinoma: More questions than answers
by: C. Moctezuma-Velázquez
Published: (2024-07-01) -
Hepatitis D Virus and Hepatocellular Carcinoma
by: Patrizia Farci, et al.
Published: (2021-05-01)